Phase II study of mitoguazone in pancreatic cancer: a Southwest Oncology Group Study.
Inamasu
M S
MS
Oishi
N
N
Chen
T T
TT
Kraut
E H
EH
Grozea
P N
PN
Costanzi
J J
JJ
Bonnet
J D
JD
D000328:Adult; D000368:Aged; D004341:Drug Evaluation; D006801:Humans; D008875:Middle Aged; D008935:Mitoguazone / Q000009:adverse effects / Q000627:therapeutic use*; D010190:Pancreatic Neoplasms / Q000188:drug therapy* / Q000473:pathology
D008935:Mitoguazone